{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T06:16:01Z","timestamp":1776492961999,"version":"3.51.2"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"45","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Prolactinomas affect patients\u2019 quality of life and even endanger lives. The study aimed to investigate the effect of the endoscopic endonasal transsphenoidal approach (EETA) on 52 patients with prolactinomas.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A total of 52 patients with prolactinomas who had previously undergone EETA in the People's Hospital of Xinjiang Uygur Autonomous Region between January 2013 and December 2017 were retrospectively analyzed. Factors affecting the extent of resection and postoperative remission rates were also investigated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>All the patients were pathologically diagnosed with prolactinomas. Compared with giant adenomas, the total removal rate of microadenomas and macroadenomas was significantly increased (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.05). In addition, the total removal rate of patients with noninvasive prolactin adenomas was significantly higher than patients with invasive prolactinadenomas (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.05). Furthermore, there were no significant differences in postoperative remission rates among patients with prolactin adenomas from different ethnic groups (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&gt;\u200a.05). Also preoperative administration of bromocriptine and preoperative prolactin (PRL) levels did not significantly affect therapeutic outcomes postsurgery (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&gt;\u200a.05). Postoperative menstruation was improved or normalized in 20 (38.5%) female patients, vision was improved or normalized in 15 (28.8%) patients, and headaches were improved or normalized in 22 (42.3%) patients. Sexual function was improved in 2 male patients following surgery. A total of 6 patients exhibited a recurrence following surgery. A number of patients suffered from postoperative complications, including transient diabetes insipidus in 5 (9.6%) patients and postoperative transient cerebrospinal fluid leakage in 2 (3.8%) patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The results of this study demonstrated that tumor size, preoperative PRL levels, and invasion of adenomas represent independent factors that can affect the success of surgery. The results suggested that EETA represents a therapeutic strategy for the treatment of patients with prolactinoma with high remission rates and low complication rates. Therefore, EETA should be considered a primary treatment for patients with prolactinomas who are not responsive to treatment with medical therapy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000013198","type":"journal-article","created":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T21:26:40Z","timestamp":1541539600000},"page":"e13198","source":"Crossref","is-referenced-by-count":31,"title":["Retrospective analysis of 52 patients with prolactinomas following endoscopic endonasal transsphenoidal surgery"],"prefix":"10.1097","volume":"97","author":[{"given":"Yan-Long","family":"Han","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi"},{"name":"Medical Graduate School of Shihezi University, Shihezi, Xinjiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Ming","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Peng","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Gang","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11102-005-5079-0","article-title":"The epidemiology of prolactinomas","volume":"8","author":"Ciccarelli","year":"2005","journal-title":"Pituitary"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2265.1994.tb02557.x","article-title":"Age-related and gender-related occurrence of pituitary adenomas","volume":"41","author":"Mindermann","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1023\/A:1009943700810","article-title":"Transsphenoidal resection of pituitary adenomas in an intraoperative MRI unit","volume":"2","author":"Martin","year":"1999","journal-title":"Pituitary"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1042-3680(02)00090-6","article-title":"Role of surgery in the treatment of microprolactinomas","volume":"14","author":"Couldwell","year":"2003","journal-title":"Neurosurg Clin N Am"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1210\/jcem.82.11.4368","article-title":"Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage","volume":"82","author":"Colao","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1210\/jcem.82.3.3822","article-title":"Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment","volume":"82","author":"Colao","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s11102-011-0368-2","article-title":"Complications of endoscopic surgery of the pituitary adenomas: analysis of 570 patients and review of the literature","volume":"15","author":"Berker","year":"2012","journal-title":"Pituitary"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11060-013-1270-8","article-title":"Management of medically refractory prolactinoma","volume":"117","author":"Molitch","year":"2014","journal-title":"J Neurooncol"},{"key":"R9-20230915","first-page":"610","article-title":"Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings","volume":"33","author":"Knosp","year":"1993","journal-title":"Neurosurgery"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11102-009-0195-x","article-title":"Endoscopic endonasal transsphenoidal surgery: surgical results of 228 pituitary adenomas treated in a pituitary center","volume":"13","author":"Gondim","year":"2010","journal-title":"Pituitary"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1007\/s00464-014-3815-0","article-title":"Endoscopic endonasal transsphenoidal surgery of 1,166 pituitary adenomas","volume":"29","author":"Wang","year":"2015","journal-title":"Surg Endosc"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.surneu.2009.04.012","article-title":"Fully endoscopic transsphenoidal surgery for functioning pituitary adenomas: a retrospectivecomparison with traditional transsphenoidal microsurgery in the same institution","volume":"72","author":"D\u2019Haens","year":"2009","journal-title":"Surg Neurol"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00701-016-2762-z","article-title":"Reasons and results of endoscopic surgery for prolactinomas: 142 surgical cases","volume":"158","author":"Akin","year":"2016","journal-title":"Acta Neurochir (Wien)"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1210\/jc.2009-1191","article-title":"Prognostic factors in prolactin pituitary tumors: clinical, histological,and molecular data from a series of 94 patients with a long postoperative follow-up","volume":"95","author":"Raverot","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R15-20230915","first-page":"72","article-title":"Factors influencing disconnection hyperprolactinemia and reversal of serum prolactin after pituitary surgery in a non-functioning pituitary macroadenoma","volume":"23","author":"Kumran","year":"2016","journal-title":"Malays J Med Sci"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1023\/A:1025334001748","article-title":"Falsely low serum prolactin in two cases of invasive macroprolactinoma","volume":"5","author":"Sch\u00f6fl","year":"2002","journal-title":"Pituitary"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11060-005-9108-7","article-title":"Giant invasive pituitary prolactinoma with falsely low serum prolactin: the significance of \u2018hook effect\u2019","volume":"79","author":"Fleseriu","year":"2006","journal-title":"J Neurooncol"},{"key":"R18-20230915","first-page":"2102","article-title":"Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study","volume":"82","author":"Delgrange","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"R213","DOI":"10.1530\/EJE-14-0013","article-title":"Therapy of endocrine disease: the challenges in managing giant prolactinomas","volume":"170","author":"Maiter","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3340\/jkns.2008.44.3.151","article-title":"Endocrine outcome of endoscopic endonasal transsphenoidal surgery in functioning pituitary adenomas","volume":"44","author":"Choe","year":"2008","journal-title":"J Korean Neurosurg Soc"},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1365-2265.2009.03665.x","article-title":"Endonasal transsphenoidal surgery and multimodality treatment for giant pituitary adenomas","volume":"72","author":"de Paiva Neto","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R22-20230915","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1227\/01.NEU.0000339121.20101.85","article-title":"Expanded endoscopic endonasal approach for anterior cranial base and suprasellar lesions: indications and limitations","volume":"64","author":"Dehdashti","year":"2009","journal-title":"Neurosurgery"},{"key":"R23-20230915","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jocn.2010.04.049","article-title":"Surgical outcome of the endoscopic endonasal approach for non-functioning giant pituitary adenoma","volume":"18","author":"Nakao","year":"2011","journal-title":"J Clin Neurosci"},{"issue":"(1 suppl)","key":"R24-20230915","first-page":"ONS44","article-title":"Endoscopic transsphenoidal pituitary surgery with intraoperative magnetic resonance imaging","volume":"58","author":"Schwartz","year":"2006","journal-title":"Neurosurgery"},{"key":"R25-20230915","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ando.2012.03.024","article-title":"2012 update in the treatment of prolactinomas","volume":"73","author":"Maiter","year":"2012","journal-title":"Ann Endocrinol (Paris)"},{"key":"R26-20230915","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000095534","article-title":"The endoscopic versus the traditional approach in pituitary surgery","volume":"83","author":"Frank","year":"2006","journal-title":"Neuroendocrinology"},{"key":"R27-20230915","first-page":"1006","article-title":"Pure endoscopic endonasal approach for pituitary adenomas: early surgical results in 200 patients and comparison with previous microsurgical series","volume":"62","author":"Dehdashti","year":"2008","journal-title":"Neurosurgery"},{"key":"R28-20230915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2176\/nmc.49.1","article-title":"Endoscopic endonasal transsphenoidal approach through the bilateral nostrils for pituitary adenomas","volume":"49","author":"Yano","year":"2009","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"R29-20230915","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1227\/00006123-198903000-00020","article-title":"Growth of prolactinoma despite lowering of serum prolactin by bromocriptine","volume":"24","author":"Kupersmith","year":"1989","journal-title":"Neurosurgery"},{"key":"R30-20230915","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1210\/jcem-58-6-1179","article-title":"Perivascular fibrosis in prolactinomas: is it increased by bromocriptine?","volume":"58","author":"Landolt","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"R31-20230915","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1507\/endocrj.45.529","article-title":"Surgical indication after bromocriptine therapy on giant prolactinomas: effects and limitations of the medical treatment","volume":"45","author":"Saeki","year":"1998","journal-title":"Endocr J"},{"key":"R32-20230915","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11060-010-0459-3","article-title":"Clinical management and outcome of 36 invasive prolactinomas treated with dopamine agonist","volume":"104","author":"Yang","year":"2011","journal-title":"J Neurooncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201811090-00081","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T21:06:17Z","timestamp":1694811977000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201811090-00081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":32,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000013198","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}